Recent Finacing
Recent Raise
Ceres Nanosciences develops Nanotrap nanoparticles to capture biomarkers and process biofluids for diagnostics, commercializing a urine-based point-of-care Lyme antigen test and adapting the platform for other diagnostic applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor